ANIK
Price
$10.83
Change
-$0.40 (-3.56%)
Updated
Jun 26 closing price
Capitalization
381.94M
34 days until earnings call
INFU
Price
$6.46
Change
+$0.06 (+0.94%)
Updated
Jun 26 closing price
Capitalization
186.74M
41 days until earnings call
Interact to see
Advertisement

ANIK vs INFU

Header iconANIK vs INFU Comparison
Open Charts ANIK vs INFUBanner chart's image
Anika Therapeutics
Price$10.83
Change-$0.40 (-3.56%)
Volume$46.62K
Capitalization381.94M
InfuSystem Holdings
Price$6.46
Change+$0.06 (+0.94%)
Volume$125.1K
Capitalization186.74M
ANIK vs INFU Comparison Chart in %
Loading...
ANIK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INFU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIK vs. INFU commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIK is a StrongBuy and INFU is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (INFU: $6.46)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INFU’s FA Score shows that 0 FA rating(s) are green while.

  • INFU’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIK’s TA Score shows that 4 TA indicator(s) are bullish while INFU’s TA Score has 5 bullish TA indicator(s).

  • ANIK’s TA Score: 4 bullish, 3 bearish.
  • INFU’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, INFU is a better buy in the short-term than ANIK.

Price Growth

INFU (@Medical Specialties) experienced а +4.36% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.93%. For the same industry, the average monthly price growth was +0.51%, and the average quarterly price growth was +0.02%.

Reported Earning Dates

INFU is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Specialties (+0.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANIK($382M) has a higher market cap than INFU($187M). INFU has higher P/E ratio than ANIK: INFU (195.13) vs ANIK (72.99). INFU YTD gains are higher at: -23.550 vs. ANIK (-34.204). INFU has higher annual earnings (EBITDA): 16.2M vs. ANIK (-11.23M). ANIK has more cash in the bank: 72.9M vs. INFU (161K). ANIK has less debt than INFU: ANIK (29M) vs INFU (36.3M). ANIK has higher revenues than INFU: ANIK (167M) vs INFU (123M).
ANIKINFUANIK / INFU
Capitalization382M187M204%
EBITDA-11.23M16.2M-69%
Gain YTD-34.204-23.550145%
P/E Ratio72.99195.1337%
Revenue167M123M136%
Total Cash72.9M161K45,280%
Total Debt29M36.3M80%
FUNDAMENTALS RATINGS
ANIK vs INFU: Fundamental Ratings
ANIK
INFU
OUTLOOK RATING
1..100
1124
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9681
PRICE GROWTH RATING
1..100
8850
P/E GROWTH RATING
1..100
74100
SEASONALITY SCORE
1..100
4550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INFU's Valuation (71) in the Medical Specialties industry is in the same range as ANIK (89) in the Pharmaceuticals Other industry. This means that INFU’s stock grew similarly to ANIK’s over the last 12 months.

INFU's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ANIK (100) in the Pharmaceuticals Other industry. This means that INFU’s stock grew similarly to ANIK’s over the last 12 months.

INFU's SMR Rating (81) in the Medical Specialties industry is in the same range as ANIK (96) in the Pharmaceuticals Other industry. This means that INFU’s stock grew similarly to ANIK’s over the last 12 months.

INFU's Price Growth Rating (50) in the Medical Specialties industry is somewhat better than the same rating for ANIK (88) in the Pharmaceuticals Other industry. This means that INFU’s stock grew somewhat faster than ANIK’s over the last 12 months.

ANIK's P/E Growth Rating (74) in the Pharmaceuticals Other industry is in the same range as INFU (100) in the Medical Specialties industry. This means that ANIK’s stock grew similarly to INFU’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIKINFU
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
53%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 18 days ago
66%
Bullish Trend 1 day ago
70%
Declines
ODDS (%)
Bearish Trend 15 days ago
70%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
64%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
ANIK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INFU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSTTX13.90N/A
N/A
Goldman Sachs Strategic Growth Inv
FCCVX35.10N/A
N/A
Fidelity Advisor Convertible Secs C
WENRX63.60N/A
N/A
Allspring Mid Cap Growth Fund - Cl R6
FEQMX42.21N/A
N/A
Fidelity Advisor Emerging Markets M
TGPEX10.86N/A
N/A
T. Rowe Price Global Impact Equity Inv

ANIK and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIK has been loosely correlated with RVTY. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIK jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIK
1D Price
Change %
ANIK100%
-3.56%
RVTY - ANIK
39%
Loosely correlated
+1.12%
AVNS - ANIK
35%
Loosely correlated
-0.81%
ACRS - ANIK
34%
Loosely correlated
-4.29%
FLGT - ANIK
32%
Poorly correlated
+0.15%
INFU - ANIK
32%
Poorly correlated
+0.94%
More

INFU and

Correlation & Price change

A.I.dvisor indicates that over the last year, INFU has been loosely correlated with ALGN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if INFU jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INFU
1D Price
Change %
INFU100%
+0.94%
ALGN - INFU
42%
Loosely correlated
+0.62%
NVST - INFU
39%
Loosely correlated
+1.55%
ICUI - INFU
38%
Loosely correlated
-1.05%
RDNT - INFU
37%
Loosely correlated
+3.48%
QDEL - INFU
36%
Loosely correlated
+2.10%
More